FDA Inspection
Blaine Labs IncBlaine Labs Inc – FDA Inspection, Dec 15, 2023
Record Details
This FDA Inspection record concerns Blaine Labs Inc, with an inspection on December 15, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 271f3b5e-30e6-4e03-9ccd-d2851bdcfd53
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1226067
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
8- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.142(b)Storage under appropriate conditions
- 21 CFR 211.63Equipment Design, Size and Location
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.142(b)Storage under appropriate conditions
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.63Equipment Design, Size and Location
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Blaine Labs Inc
8| Date | Classification | Office | Project area |
|---|---|---|---|
| December 22, 2025 | OAI | Los Angeles District Office | Drug Quality Assurance |
| August 24, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 30, 2019 | Not classified | Los Angeles District Office | Drug Quality Assurance |
| March 24, 2016 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| November 16, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Blaine Labs Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.